Friday, October 23, 2026
BTC $80,536 ▼ 0.68%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
ADA$0.209down−0.69%ETH$2,368down−0.68%LINK$11.71down−0.91%SOL$101.90down−0.80%BTC$80,536down−0.68%XRP$1.28down−0.80%S&P 5007,624down−0.52%Nasdaq25,955down−0.21%Dow52,215down−1.23%RUT2,776down−0.29%TNX4.99%up+0.71%TYX5.32%up+0.53%FVX4.80%up+0.78%IRX4.03%up+0.25%VIX19.45up+2.21%GOLD$4,010.00down−1.24%SILVER$53.96down−1.90%OIL$103.44up+3.99%DXY101.75up+0.14%NVDA$210.96down−0.59%AAPL$347.73down−0.14%TSLA$372.22down−0.63%META$642.62down−0.96%MSFT$524.51up+0.66%AMZN$248.00down−0.95%GOOGL$320.21down−1.24%Fear & Greed51 — NeutralADA$0.209down−0.69%ETH$2,368down−0.68%LINK$11.71down−0.91%SOL$101.90down−0.80%BTC$80,536down−0.68%XRP$1.28down−0.80%S&P 5007,624down−0.52%Nasdaq25,955down−0.21%Dow52,215down−1.23%RUT2,776down−0.29%TNX4.99%up+0.71%TYX5.32%up+0.53%FVX4.80%up+0.78%IRX4.03%up+0.25%VIX19.45up+2.21%GOLD$4,010.00down−1.24%SILVER$53.96down−1.90%OIL$103.44up+3.99%DXY101.75up+0.14%NVDA$210.96down−0.59%AAPL$347.73down−0.14%TSLA$372.22down−0.63%META$642.62down−0.96%MSFT$524.51up+0.66%AMZN$248.00down−0.95%GOOGL$320.21down−1.24%Fear & Greed51 — Neutral
Tag

haemophilia a

1 article

Novo Nordisk Delays Denecimig US Launch to H1 2027 on Manufacturing Issues
U.S. Equities20d ago
Novo Nordisk Delays Denecimig US Launch to H1 2027 on Manufacturing Issues
FDA manufacturing facility concerns push haemophilia A treatment past original 2026 target; clinical data deemed acceptable